Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

The impact of high and low BMI on osteoporosis risk: a systematic review and meta-analysis

  1. 1School of Pediatrics, Nanjing Medical University
  2. 2Tianyuan College, Nanjing Medical University

Abstract

Background: Low body mass index (BMI) has long been associated with osteoporosis, whereas higher BMI has frequently been associated with more favorable skeletal outcomes. However, BMI does not distinguish between lean mass and fat mass, and whether the inverse association between higher BMI and osteoporosis reflects a beneficial effect of adiposity itself remains uncertain. This systematic review and meta-analysis aimed to evaluate the associations of low and high BMI with osteoporosis risk within a common analytical framework.

Methods: We systematically searched PubMed, Web of Science, and the Cochrane Library for studies published from January 1, 1993 to August 19, 2026 that examined the association between BMI and osteoporosis. Eligible studies evaluated BMI as a continuous exposure and/or according to predefined weight categories and reported effect estimates for osteoporosis. Study selection and data extraction were performed independently by two reviewers. Random-effects meta-analyses were conducted separately for continuous BMI, underweight, overweight, and obesity, and between-study heterogeneity was assessed using the I ² statistic. A total of 22 studies were included in the systematic review.

Results: In the quantitative synthesis, continuous BMI was inversely associated with osteoporosis (pooled OR = 0.878, 95% CI: 0.866–0.891; I ² = 60.3%). Underweight was associated with higher pooled odds of osteoporosis, although the association did not reach statistical significance (OR = 2.295, 95% CI: 0.963–5.469; I ² = 85.6%). In contrast, overweight (OR = 0.462, 95% CI: 0.403–0.530; I ² = 0%) and obesity (OR = 0.229, 95% CI: 0.191–0.273; I ² = 0%) were associated with lower odds of osteoporosis compared with the reference BMI categories. Moderate-to-substantial heterogeneity was observed in the continuous BMI analysis, whereas substantial heterogeneity was present in the underweight analysis. No statistically detectable between-study heterogeneity was observed for overweight and obesity.

Conclusion: Continuous BMI was inversely associated with osteoporosis, while overweight and obesity were associated with lower odds of osteoporosis. Underweight showed higher pooled odds, although the association was not statistically significant. Moderate heterogeneity was observed for continuous BMI and substantial heterogeneity for underweight. These findings should therefore be interpreted cautiously. Importantly, the inverse association between higher BMI and osteoporosis should not be considered evidence that adiposity itself is protective, as BMI does not distinguish lean mass from fat mass. Future studies incorporating body-composition measures are needed to clarify the relationships among BMI, adiposity, lean mass, and osteoporosis risk.

Related

  1. Prevalence and risk factors of postmenopausal osteoporosis: a systematic review and meta-analysis based on multivariate logistic regression
    Zhao Qin, Jun Liao, Xiaoming Peng +3
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  2. Effects of different anti-osteoporosis medications on re-fracture risk, bone mineral density, and functional recovery following hip fragility fracture surgery: a systematic review and network meta-analysis
    Jingnan Tian, Hang Zhang, Yuchi Lu +5
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMCPMC
  3. Impact of low bone mass and osteoporosis on lower limb alignment and knee function in high tibial osteotomy for varus knee osteoarthritis
    Zhipeng Xue, Xiaomin Li, Ye Huang +3
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Acute Kidney Injury After Percutaneous Left Atrial Appendage Occlusion: Incidence, Risk Factors, Clinical Impact, and Contrast-Sparing Strategies—A Systematic Review
    Josipa Radić, Tina Bečić, Marijana Vučković +4
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefEurope PMC
  5. Risk of Short-Term Stroke in Non-High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement vs Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis
    Haochen Liu, Zhidan Xiao, Jiahao Zou +1
    Reviews in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
BibTeX
@article{wang2026impact,
  title = {{The impact of high and low BMI on osteoporosis risk: a systematic review and meta-analysis}},
  author = {Yucheng Wang and Yao Gu},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = nov,
  doi = {10.3389/fendo.2026.1908405},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1908405/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The impact of high and low BMI on osteoporosis risk: a systematic review and meta-analysis
AU  - Yucheng Wang
AU  - Yao Gu
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1908405
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.1908405/full
AB  - Background: Low body mass index (BMI) has long been associated with osteoporosis, whereas higher BMI has frequently been associated with more favorable skeletal outcomes. However, BMI does not distinguish between lean mass and fat mass, and whether the inverse association between higher BMI and osteoporosis reflects a beneficial effect of adiposity itself remains uncertain. This systematic review and meta-analysis aimed to evaluate the associations of low and high BMI with osteoporosis risk within a common analytical framework.  Methods: We systematically searched PubMed, Web of Science, and the Cochrane Library for studies published from January 1, 1993 to August 19, 2026 that examined the association between BMI and osteoporosis. Eligible studies evaluated BMI as a continuous exposure and/or according to predefined weight categories and reported effect estimates for osteoporosis. Study selection and data extraction were performed independently by two reviewers. Random-effects meta-analyses were conducted separately for continuous BMI, underweight, overweight, and obesity, and between-study heterogeneity was assessed using the I ² statistic. A total of 22 studies were included in the systematic review.  Results: In the quantitative synthesis, continuous BMI was inversely associated with osteoporosis (pooled OR = 0.878, 95% CI: 0.866–0.891; I ² = 60.3%). Underweight was associated with higher pooled odds of osteoporosis, although the association did not reach statistical significance (OR = 2.295, 95% CI: 0.963–5.469; I ² = 85.6%). In contrast, overweight (OR = 0.462, 95% CI: 0.403–0.530; I ² = 0%) and obesity (OR = 0.229, 95% CI: 0.191–0.273; I ² = 0%) were associated with lower odds of osteoporosis compared with the reference BMI categories. Moderate-to-substantial heterogeneity was observed in the continuous BMI analysis, whereas substantial heterogeneity was present in the underweight analysis. No statistically detectable between-study heterogeneity was observed for overweight and obesity.  Conclusion: Continuous BMI was inversely associated with osteoporosis, while overweight and obesity were associated with lower odds of osteoporosis. Underweight showed higher pooled odds, although the association was not statistically significant. Moderate heterogeneity was observed for continuous BMI and substantial heterogeneity for underweight. These findings should therefore be interpreted cautiously. Importantly, the inverse association between higher BMI and osteoporosis should not be considered evidence that adiposity itself is protective, as BMI does not distinguish lean mass from fat mass. Future studies incorporating body-composition measures are needed to clarify the relationships among BMI, adiposity, lean mass, and osteoporosis risk.
SN  - 1664-2392
ER  -